Hypophosphatemia With Intravenous Ferric Carboxymaltose Versus Iron Dextran in Women With Iron Deficiency Secondary to Heavy Uterine Bleeding

The recruitment status of this study is unknown because the information has not been verified recently.

Verified May 2011 by Luitpold Pharmaceuticals.
Recruitment status was Active, not recruiting

Study NCT01307007 Information provided by Luitpold Pharmaceuticals

First Received on October 4, 2010. Last Updated on May 2, 2011 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

Dextrans
Ferric Compounds
Iron
Iron-Dextran Complex

More general drug interventions related to this trial

Sponsors listed in this trial